These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26658998)

  • 21. MiRNAs roles in the diagnosis, prognosis and treatment of colorectal cancer.
    Sur DG; Colceriu M; Sur G; Aldea C; Silaghi C; Samasca G; Lupan I; Căinap C; Burz C; Irimie A
    Expert Rev Proteomics; 2019 Oct; 16(10):851-856. PubMed ID: 31446809
    [No Abstract]   [Full Text] [Related]  

  • 22. Biomarkers in Colorectal Cancer.
    Yiu AJ; Yiu CY
    Anticancer Res; 2016 Mar; 36(3):1093-102. PubMed ID: 26977004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of miRNAs in colorectal cancer progression and chemoradiotherapy.
    Zhang N; Hu X; Du Y; Du J
    Biomed Pharmacother; 2021 Feb; 134():111099. PubMed ID: 33338745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathological role of microRNAs and inflammation in colon carcinogenesis.
    Zhang L; Fan XM
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):174-9. PubMed ID: 25154001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
    Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
    Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.
    Tokarz P; Blasiak J
    Acta Biochim Pol; 2012; 59(4):467-74. PubMed ID: 23173124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenetic and clinical relevance of microRNAs in colorectal cancer.
    Valeri N; Croce CM; Fabbri M
    Cancer Genomics Proteomics; 2009; 6(4):195-204. PubMed ID: 19656996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular biomarkers in colorectal carcinoma.
    Puerta-García E; Cañadas-Garre M; Calleja-Hernández MÁ
    Pharmacogenomics; 2015; 16(10):1189-222. PubMed ID: 26237292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA biomarkers predicting risk, initiation and progression of colorectal cancer.
    Lee K; Ferguson LR
    World J Gastroenterol; 2016 Sep; 22(33):7389-401. PubMed ID: 27672263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of microRNAs in colorectal cancer.
    Liu M; Chen H
    J Genet Genomics; 2010 Jun; 37(6):347-58. PubMed ID: 20621017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using Blood and Plasma MicroRNAs as a Non-Invasive Biomarker in Patients with Colorectal Cancer.
    Stefanescu H; Muntean D; Pilut C; Diaconu M; Popescu R; Hutanu D; Moise M; Diana L; Nitu R; Cherecheanu AP; Negoita S; Iovan CV; Ungureanu E; Calu V; Ciuca I
    Clin Lab; 2018 Mar; 64(3):257-262. PubMed ID: 29739108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNAs: Small molecules with a large impact on colorectal cancer.
    Moazzendizaji S; Sevbitov A; Ezzatifar F; Jalili HR; Aalii M; Hemmatzadeh M; Aslani S; Gholizadeh Navashenaq J; Safari R; Hosseinzadeh R; Rahmany MR; Mohammadi H
    Biotechnol Appl Biochem; 2022 Oct; 69(5):1893-1908. PubMed ID: 34550619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of MicroRNA in the Diagnosis and Therapy of Hepatic Metastases from Colorectal Cancer.
    Chorti A; Bangeas P; Papavramidis TS; Tsoulfas G
    Microrna; 2018; 7(3):167-177. PubMed ID: 29793419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
    Zhang Y; Wang X; Wang Z; Tang H; Fan H; Guo Q
    Oncol Rep; 2015 May; 33(5):2592-8. PubMed ID: 25738520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment.
    Bonfrate L; Altomare DF; Di Lena M; Travaglio E; Rotelli MT; De Luca A; Portincasa P
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):311-20. PubMed ID: 24078989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
    Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
    Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA biomarkers in colorectal cancer.
    Bustin SA; Murphy J
    Methods; 2013 Jan; 59(1):116-25. PubMed ID: 23079397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miRNA-144 suppresses proliferation and migration of colorectal cancer cells through GSPT1.
    Xiao R; Li C; Chai B
    Biomed Pharmacother; 2015 Aug; 74():138-44. PubMed ID: 26349975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanisms and clinical uses of miRNAs in colorectal cancer].
    Ogawa Y; Mimori K
    Nihon Rinsho; 2016 Nov; 74(11):1807-1811. PubMed ID: 30550686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.